Group One Trading’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-50
Closed -$3K 8926
2021
Q4
$3K Buy
50
+35
+233% +$2.35K ﹤0.01% 7830
2021
Q3
$1K Sell
15
-555
-97% -$42.5K ﹤0.01% 8058
2021
Q2
$55K Buy
570
+115
+25% +$12.7K ﹤0.01% 6498
2021
Q1
$67K Buy
+455
New +$82.5K ﹤0.01% 6011
2018
Q3
Sell
-51
Closed -$4K 5717
2018
Q2
$4K Hold
51
﹤0.01% 4863
2018
Q1
$5K Sell
51
-61
-54% -$9.07K ﹤0.01% 4519
2017
Q4
$84K Buy
+112
New +$43.2K ﹤0.01% 3454
2017
Q3
Sell
-10
Closed -$3K 5256
2017
Q2
$3K Sell
10
-3
-23% -$806 ﹤0.01% 4527
2017
Q1
$4K Sell
13
-36
-73% -$16.7K ﹤0.01% 4353
2016
Q4
$29K Sell
49
-2
-4% -$2.11K ﹤0.01% 3551
2016
Q3
$57K Sell
51
-70
-58% -$75.5K ﹤0.01% 3277
2016
Q2
$132K Sell
121
-20
-14% -$25.1K ﹤0.01% 2675
2016
Q1
$181K Sell
141
-603
-81% -$859K ﹤0.01% 2392
2015
Q4
$1.83M Buy
744
+719
+2,876% +$1.1M 0.02% 916
2015
Q3
$27K Sell
25
-3
-11% -$3.48K ﹤0.01% 3903
2015
Q2
$28K Sell
28
-110
-80% -$119K ﹤0.01% 3886
2015
Q1
$140K Buy
138
+28
+25% +$92.4K ﹤0.01% 2652
2014
Q4
$365K Buy
110
+22
+25% +$67.4K 0.01% 1802
2014
Q3
$254K Sell
88
-573
-87% -$1.9M ﹤0.01% 2194
2014
Q2
$2.52M Buy
661
+656
+13,120% +$2.47M 0.04% 573
2014
Q1
$29K Buy
+5
New +$26.3K ﹤0.01% 4006

Other funds holding NBSE

Group One Trading's NBSE Position: Q1 2021 in Review

Group One Trading sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q1 2021, closing a stake of 193 shares — an estimated $35K sold.

Group One Trading first reported a position in NBSE in Q1 2014 and held it in 15 quarters. The position peaked at $322K in Q1 2014. 56 funds tracked by Wall St. Rank hold NBSE as of Q1 2021.

  • Group One Trading reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Group One Trading sold 193 NeuBase Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $35K.
  • Group One Trading first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2014 and held it in 15 quarters.
  • Group One Trading's NeuBase Therapeutics, Inc. Common Stock position peaked at $322K in Q1 2014.
  • 56 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Group One Trading's 13F filing for Q1 2021, filed 12 May 2021.